The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Centre — Val de Loire; Centre — Val de Loire; Eure-et-Loir
Location of affected unit(s)
Chartres
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21.2 - Manufacture of pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
11 August 2026
Employment effect (start)
1 September 2026
Foreseen end date
31 December 2026
Description
Gi Life Sciences Chartres, a subsidiary of the Italian Gi Group Holding, announced in November 2026 a recruitment campaign for 100 production operators at its Chartres manufacturing site by the end of 2026, as part of a broader plan to create 500 jobs by 2030. The expansion will increase capacity to meet growing pharmaceutical demand. All new hires will work in the Chartres facility’s controlled atmosphere production zone and will be trained for aseptic manufacturing standards. The initiative reinforces Gi Life Sciences Chartres’ commitment to local employment and supports Gi Group Holding’s strategy of expanding its presence in France.
Citation
Eurofound (2026), Gi Life Sciences Chartres, Business expansion in France, factsheet number 300858, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300858.